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ARTICLE

H2-M3–restricted CD8+ T cells are not
required for MHC class Ib–restricted
immunity against Listeria monocytogenes
Sarah E.F. D’Orazio,1 Christine A. Shaw,2 and Michael N. Starnbach2
1Department

The Journal of Experimental Medicine

of Microbiology, Immunology, and Molecular Genetics, University of Kentucky College of Medicine,
Lexington, KY 40536
2Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, MA 02115

Studies using major histocompatibility complex (MHC)-Ia–deficient mice have shown that
MHC-Ib–restricted CD8+ T cells can clear infections caused by intracellular pathogens such
as Listeria monocytogenes. M3-restricted CD8+ T cells, which recognize short hydrophobic
N-formylated peptides, appear to comprise a substantial portion of the MHC-Ib–restricted
T cell response in the mouse model of L. monocytogenes infection. In this study, we isolated
formyltransferase (fmt) mutant strains of L. monocytogenes that lacked the ability to add
formyl groups to nascent polypeptides. These fmt mutant Listeria strains did not produce
antigens that could be recognized by M3-restricted T cells. We showed that immunization
of MHC-Ia–deficient mice with fmt mutant Listeria resulted in stimulation of a protective
memory response that cleared subsequent challenge with wild-type L. monocytogenes,
despite the fact that M3-restricted CD8+ T cells did not proliferate in these mice. These
data suggest that M3-restricted T cells are not required for protection against L. monocytogenes and underscore the importance of searching for new antigen-presenting molecules
among the large MHC-Ib family of proteins.

CORRESPONDENCE
Michael N. Starnbach:
starnbach@hms.harvard.edu
Abbreviations used: ActR,
actinonin-resistant; BHI, brain
heart infusion; BMMΦ, bone
marrow–derived macrophages;
fmt, formyltransferase; ICCS,
intracellular cytokine staining;
MTF, methionyl-tRNAfMet
formyltransferase; PDF, peptide
deformlyase.

Although innate immune responses are essential
to limit the spread of intracellular bacterial infections, it is the adaptive immune response that
allows the body to completely clear tremendous
bacterial burdens. Memory CD8+ T cells that
recognize antigens presented by MHC-I on the
surface of infected cells are generally thought to
be required for clearance of intracellular pathogens. Mice express two groups of MHC-I
proteins: (a) the classically studied MHC-Ia molecules (K, D, and L) and (b) the nonclassical or
MHC-Ib proteins, including Q, T, and M gene
products. Much effort has been devoted to identifying peptide antigens within bacterial proteins
that are predicted to bind to classical MHC-I
molecules. For example, at least four dominant
Kd-binding epitopes derived from secreted virulence factors are known to be presented during
Listeria monocytogenes infection, and several other
subdominant epitopes have also been identified
(1, 2). However, in recent years, it has become
increasingly clear that the nonclassical MHC-Ib
molecules can also present antigens to T cells
during bacterial infection (3).
The online version of this article contains supplemental material.
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Nonclassical MHC-I molecules are a widely
diverse set of proteins encoded both within and
outside the MHC locus that have been collectively referred to as MHC-Ib. It is difficult to
make generalizations about MHC-Ib molecules because of the diversity of the members of
this protein family; however, many differences
from classical MHC-I have been observed.
Cell surface levels of many MHC-Ib proteins
are lower than MHC-Ia and some MHC-Ib
molecules display a tissue-specific expression
pattern, unlike MHC-Ia molecules that are
ubiquitously expressed (4, 5). MHC-Ib molecules have also been shown to bind a more diverse set of antigens than MHC-Ia, which bind
only 8–10 mer peptides. For example, during
Mycobacterium tuberculosis infection, CD1 proteins present lipid molecules to T cells (6, 7).
When mice are infected with L. monocytogenes,
CD8+ T cells recognize formylated peptides
bound to M3 (8).
Although our knowledge of most MHC-Ib
molecules is limited, M3 has been studied in
great detail. The peptide-binding groove of
M3 is shallower than classical MHC-I molecules
and it has been demonstrated to specifically
383

Table I. Characterization of actinonin-resistant
L. monocytogenes strains
Strain

Figure 1. Actinonin inhibits bacterial peptide deformylase (PDF)
activity. Bacterial methionyl-tRNAfMet formyltransferase (MTF) adds a
formyl group to methionines that are bound to initiator tRNAs. Formylation promotes binding of initiator factor 2 (IF-2) and impairs binding
of elongation factor Tu and, therefore, provides a basis for the initiation
of protein synthesis. The formyl group is cleaved from the mature protein
by peptide deformylase (PDF), and in many cases the NH2-terminal methionine is removed by methionine amino peptidase (not depicted). Actinonin is a naturally occurring inhibitor of metallohydrolases that blocks PDF
activity in bacteria (reference 20).

bind short (5–6 mer) hydrophobic peptides with an NH2terminal formylated methionine (9–11). It has been suggested
that M3 evolved specifically to present bacterial antigens to
the mammalian immune system because N-formylation is
used as a signal to initiate protein synthesis only in prokaryotes and for a limited set of mitochondrial and chloroplast
proteins. At least three formylated peptides derived from
L. monocytogenes (fMIVIL, fMIGWII, and fMIVTLF) have
been shown to bind M3, and T cells that recognize each of
these peptides are known to be activated during Listeria infection (12–14). In fact, in BALB/c mice, the magnitude of the
fMIGWII-specific T cell response is nearly as great as the immunodominant Kd-binding LLO91-99 T cell response (8).
Using MHC-Ia–deficient mice, we and others have
shown that MHC-Ib–restricted CD8+ T cells alone are sufficient to clear infection with the intracellular bacterial pathogen L. monocytogenes (15, 16). It has been suggested that
M3-restricted T cells are largely responsible for this protective immunity in mice (17). If this were true, use of the
L. monocytogenes murine infection model would be more limited as a tool to study the role of MHC-Ib–restricted T cells
in human immunity against intracellular pathogens because
no human homologue for M3 has yet been discovered.
The purpose of this study was to determine whether
MHC-Ib molecules other than M3 could mediate protective
immunity against L. monocytogenes infection. We used an actinonin resistance selection strategy to generate mutant strains
of L. monocytogenes that lacked the necessary enzyme systems
to incorporate formylmethionine at the NH2 terminus of
newly synthesized proteins. Mice infected with these mutant
strains were therefore unable to present formylated peptide
antigens derived from L. monocytogenes to naive M3-restricted
CD8+ T cells. We found that activation and proliferation of
M3-restricted CD8+ T cells was not required for protective
immunity against Listeria in MHC-Ia–deficient mice, suggesting that other MHC-Ib must be capable of presenting
384

fmt genotype

10403s

Wild type

SD-A1
SD-A4
SD-A8

Insertion (G) at bp 514a
Deletion (A) at bp 267
Insertion (G) at bp 396

abp

Composition of predicted
MTF protein
Complete coding sequence,
313 aa
Frameshift after 171 aa
Frameshift after 89 aa
Frameshift after 132 aa

refer to the nucleotide position within the 939 bp of the wt fmt ORF.

antigens to T cells and stimulating a memory CD8+ T cell
response. These data underscore the importance of discovering
new classes of MHC-Ib molecules and identifying the types
of antigens presented by these MHC-Ib family members.
RESULTS
Selection of L. monocytogenes strains containing
formyltransferase (fmt) mutations
Previous studies have shown that formylation is not essential
for initiation of protein synthesis in either Pseudomonas aeruginosa (18) or Staphylococcus aureus (19). We predicted that formylation would similarly not be required for protein synthesis
in L. monocytogenes and that it would be possible to select for
a mutant strain incapable of formylating nascent polypeptides. Such a strain could then be used as a tool to determine
the role of M3-restricted T cells in MHC-Ib–mediated antiListeria immunity. We used actinonin, a naturally occurring
peptide deformlyase (PDF) inhibitor (20), to select for spontaneous fmt mutants in Listeria. Failure to remove formyl groups
from the NH2-terminal methionine of newly synthesized
proteins is toxic to most bacteria; however, if formyl groups
are never added, then PDF activity would not be required,
and bacteria should grow readily in the presence of actinonin
(Fig. 1). Margolis et al. previously showed that growth of
S. aureus in the presence of actinonin resulted in the appearance of actinonin-resistant (ActR) colonies that had spontaneous mutations in the S. aureus fmt gene (19). We used a
similar selection strategy to isolate Listeria fmt mutants.
Wild-type L. monocytogenes 10403s was plated on brain–
heart infusion (BHI) agar containing 100 μg/ml actinonin.
Spontaneous ActR colonies arose at a frequency of 1.25 ×
10−6. Three ActR colonies were passaged 25 times on BHI
plates lacking antibiotics and inoculated onto BHI agar with
or without actinonin. No actinonin-sensitive revertants were
observed and the resulting strains were named L. monocytogenes SD-A1, SD-A4, and SD-A8. DNA sequence analysis
revealed that all three ActR strains contained frameshift mutations in the fmt gene (Table I). Strains SD-A1, SD-A4, and
SD-A8 were each predicted to encode methionyl-tRNAfMet
formyltransferase (MTF) proteins truncated at the COOH
terminus. The COOH-terminal portion of MTF is thought
to be necessary for binding to methionine-loaded tRNAfMet
(21); therefore, these truncated proteins should lack the ability to formylate nascent polypeptides.
MTF MUTANT LISTERIA LACK M3-BINDING PEPTIDES | D’Orazio et al.
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Figure 2. The doubling time of fmt mutant Listeria is increased
compared with wild-type Listeria during growth in BHI broth.
Freshly streaked wild-type (Lm 10403s) or fmt mutant (SD-A1, SD-A4,
SD-A8) L. monocytogenes strains were incubated overnight at 37°C with
aeration in BHI broth. The next day, each culture was diluted to an OD550
of 0.015 in fresh BHI broth and further incubated at 37°C with aeration.
Bacterial growth was assessed by determining the OD550 at various time
points as indicated. Representative data from one of two different
experiments are shown.

fmt mutant L. monocytogenes have an increased doubling
time compared with wild-type L. monocytogenes
After 24–48 h of incubation at 37°C on BHI agar, colonies of
the fmt mutant L. monocytogenes grew to only approximately
half the size of wild-type Listeria colonies, suggesting that the
fmt mutants had a slower growth rate. In fact, all three fmt
mutant strains had a twofold increase in doubling time when
grown in BHI broth (Fig. 2). Even after 48 h of incubation,
growth of the fmt mutant strains did not reach the same density as wild-type L. monocytogenes (unpublished data). Slower
growth rates have also been observed for fmt mutant strains of
P. aeuruginosa (18) and S. aureus (19). Collectively, these results suggest that using formylation to initiate protein synthesis enhances bacterial growth, but that formylation is not
essential for in vitro growth of these bacteria.
No intracellular growth defect is observed for fmt
mutant L. monocytogenes
Wild-type L. monocytogenes encode several virulence factors
that allow the bacteria to readily enter mammalian cells, escape from endocytic vesicles, and grow within the cytoplasm
of infected cells. As shown in Fig. 3, we tested a variety of
different cell types and found no difference in the ability of
either fmt mutant or wild-type Listeria strains to replicate inside cells. In both L2 fibroblasts (Fig. 3 A) and Hepa1-6 liver
epithelial cells (Fig. 3 B), the growth rate for strains SD-A1
and SD-A8 was indistinguishable from the wild-type strain
10403s. In J774 macrophage-like cells, we recovered fewer
intracellular fmt mutant Listeria than wild-type Listeria 1 h after
infection (Fig. 3 C). However, the growth rate over the next
7 h in J774 cells was the same for all three strains. These data
demonstrate that intracellular growth of the fmt mutant Listeria strains was not impaired compared with wild-type Listeria.
JEM VOL. 203, February 20, 2006

Figure 3. fmt mutant Listeria do not have a replication defect
during intracellular growth. Monolayers of L2 fibroblasts, Hepa1-6
epithelial cells, or J774 macrophage-like cells plated on glass coverslips
were infected with the Listeria strains indicated for 30 min, washed extensively, and incubated in media containing 25 μg/ml gentamicin to kill
extracellular bacteria. At each of the time points indicated, the cells attached to each coverslip were lysed in sterile water to release intracellular
bacteria. Serial dilutions of each lysate were plated on BHI agar to determine the total number of bacterial colony forming units (CFU) associated
with each coverslip. Data shown represent the average values ± SD for
triplicate coverslips from one of two separate experiments.

N-formylated peptides do not accumulate in the
supernatants of fmt mutant Listeria cultures
Formylated MIGWII (f-MIGWII), an M3-binding peptide
derived from the L. monocytogenes LemA protein, has been
shown to accumulate over time in the culture supernatant
when L. monocytogenes is grown in broth (22). The mechanism for this accumulation of formylated peptide is not
known, but it is thought that extracellular proteases could
cleave the NH2-terminal portion of LemA, which is predicted to have an “Nout” topology. Presumably, this orientation protects the formyl group on the peptide from PDF
activity in the bacterial cytoplasm. To ensure that formylation
was not occurring in the fmt mutant strains, we used a T cell
cytotoxicity assay to measure the amount of fMIGWII peptide found in either wild-type or fmt mutant Listeria culture
supernatants. Target cells were pretreated with Listeria culture supernatant and exposed to the fMIGWII-specific CD8+
T cell line S172. Line S172 is able to lyse target cells coated
385

Figure 4. Formylated peptides do not accumulate in the culture
supernatants of fmt mutant Listeria strains. T cell recognition of target cells was measured as a function of cytotoxicity (51Cr release into the
supernatant) and is shown as percentage of specific lysis. (A) 51Cr-loaded
EL-4 target cells were pretreated with media alone (BHI broth) or culture
supernatant derived from either wild-type (wt Lm) or fmt mutant
(SD-A1, SD-A8) L. monocytogenes strains. CD8+ T cells were added at
various effector to target ratios and the cells were coincubated for 4 h.
Line S172 T cells recognize N-formylated MIGWII peptide bound to M3;
clone 2.5 is an M3-restricted CD8+ T clone of unknown specificity. (B)
51Cr-loaded EL-4 target cells were pretreated with synthetic peptide at
the final concentrations indicated. Line S172 T cells were added at an
effector: target ratio of 45:1.

with picomolar or greater concentrations of formylated
MIGWII peptide but not unformylated peptide (Fig. 4 B). As
shown in Fig. 4 A, line S172 CD8+ T cells lysed target cells
treated with supernatant from wild-type Listeria, but did not
lyse targets treated with either SD-A1 or SD-A8 supernatant.
In addition, the CD8+ T cell clone 2.5, which recognizes an
as yet unidentified Listeria antigen bound to M3 (unpublished
data) was also not capable of lysing target cells treated with
supernatant from fmt mutant Listeria. The lower limit of detection for the recognition of formylated peptides by CD8+
T cells using the cytotoxicity assay was 10−11M (Fig. 4 B).
These results suggested that N-formylated proteins were not
present in the fmt mutant Listeria strains to provide a source of
M3-binding peptides.
fmt mutant Listeria establish infection in mouse spleen,
but have an impaired ability to replicate in mouse liver
Before characterizing the adaptive immune response against
the fmt mutant Listeria in vivo, we first tested whether or not
the fmt mutant strains were virulent enough to establish a
sustained infection in mice that would allow for processing
386

Figure 5. fmt mutant Listeria are less virulent in the liver than in
the spleen. (A) A competitive index assay was used to determine the
relative virulence of fmt mutant Listeria strains SD-A1 and SD-A8 compared with wild-type Listeria. BALB/c mice were sublethally infected intravenously with a 1:1 mixture of wild-type (erythromycin-resistant) and
mutant Listeria (erythromycin-sensitive). Mice were killed 3 d later and
the spleens and livers were homogenized and differentially plated to determine the total number of each bacterial strain present. Squares represent competitive indices for individual mice; thick black lines represent
average indices for groups of mice. (B) A plaque assay was used to assess
the degree of cell-to-spread achieved by fmt mutant Lm SD-A1 compared
with wild-type Lm 10403s. Confluent monolayers of L2 fibroblasts were
infected at low MOI (0.1) for 1 h and agarose overlays were added. After
3 d of incubation at 37°C in 7% CO2, neutral red overlays were added to
visualize the plaques. Plaque size indicates the relative degree of cell-tocell spread for each strain. Infections were performed in duplicate wells in
two separate experiments.

and presentation of bacterial antigens to the immune system.
We used a competitive index assay to compare the virulence
of the fmt mutant strains to wild-type L. monocytogenes DPL3903. BALB/c mice were infected with a 1:1 mixture of
wild-type (erythromycin-resistant) and fmt mutant L. monocytogenes (erythromycin-sensitive). 3 d later, liver and spleen
homogenates from each mouse were differentially plated on
media with or without erythromycin to determine the total
number of CFU of each Listeria strain present. As shown in
Fig. 5 A, approximately equal numbers of wild-type and fmt
mutant L. monocytogenes were recovered from the spleen of
each mouse, indicating that fmt mutant Listeria were fully able
to compete with wild-type Listeria for growth in the spleen.
However, at least 10-fold fewer SD-A1 or SD-A8 L. monocytogenes were recovered from mouse livers compared with
wild-type Listeria (Fig. 5 A), suggesting that the fmt mutant
strains were less virulent in the liver and not able to compete
with wild-type L. monocytogenes for growth.
A growth defect in the liver, but not the spleen, has also
been observed for L. monocytogenes strains with mutations in
the actA gene (23). ActA mutants are unable to spread efficiently from cell to cell and form smaller plaques than wildtype L. monocytogenes when assayed on cell monolayers.
Similarly, we have observed that fmt mutant Listeria formed
MTF MUTANT LISTERIA LACK M3-BINDING PEPTIDES | D’Orazio et al.
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plaques in cell monolayers that were only half the size of
plaques formed by wild-type L. monocytogenes (Fig. 5 B). In
L2 fibroblasts, strains SD-A1 and SD-A8 formed plaques that
were 63% and 54% of wild-type size, respectively. Similar results were observed when monolayers of Hepa1-6 epithelial
cells were infected with L. monocytogenes fmt mutants (55% for
SD-A1 and 61% for SD-A8). Collectively, these results suggest that fmt mutant Listeria are readily able to infect single
cells but that their ability to spread to adjacent cells is impaired compared with wild-type L. monocytogenes.
M3-restricted CD8+ T cells are not activated in mice
immunized with fmt mutant L. monocytogenes
To confirm that M3-restricted CD8+ T cells were not activated in mice infected with fmt mutant Listeria, we harvested
splenocytes from mice 7 d after infection and determined
the number of fMIGWII-specific CD8+ T cells present. In
naive BALB/c mice, 0.3% of all CD8+ T cells secreted
IFNγ after incubation with fMIGWII, the immunodominant
M3-binding peptide epitope derived from L. monocytogenes
(Fig. 6 A and Fig. S1, available at http://www.jem.org/cgi/
content/full/jem.20052256/DC1). 7 d after infection with
wild-type Listeria, those T cells had expanded 10-fold.
However, no increase in the number of fMIGWII-specific T
cells was observed in spleens of BALB/c mice infected with
either SD-A1 or SD-A8. Similar results were observed when
MHC-Ia–deficient mice were used (unpublished data). As
a control, we also counted the number of LLO91-99-specific
CD8+ T cells found in the spleens of BALB/c mice infected
with either wild-type or fmt mutant Listeria. A significant increase in the number of LLO91-99-specific CD8+ T cells was
observed after infection with all three Listeria strains (Fig. 6 A).
Therefore, the fmt mutant Listeria were able to infect enough
cells to allow for sufficient processing and presentation of a
MHC-Ia (Kd)-binding peptide to naive CD8+ T cells.
Although the fmt mutant Listeria did not appear to be producing formylated MIGWII peptide antigen, significant quantities of unformylated MIGWII peptide could be present in the
cytoplasm of cells infected with either strain SD-A1 or SD-A8.
Unformylated peptides bind to M3 with a much lower affinity than formylated peptides, and it has been thought that
unformylated peptide bound to M3 would not stimulate naive
CD8+ T cells in vivo. To verify that infection with fmt mutant Listeria did not result in activation of any M3-restricted
MIGWII-specific CD8+ T cells, we also counted the number
of T cells present that could recognize unformylated MIGWII
peptide. Splenocytes harvested from mice infected with wildtype or fmt mutant Listeria 7 d earlier were exposed to high
concentrations of either fMIGWII or MIGWII and the number of CD8+ T cells that produced IFNγ in response to these
stimuli was assessed by intracellular cytokine staining (ICCS).
As shown in Fig. 6 B, the number of MIGWII-specific T cells
present in the spleens of mice infected with either strain SDA1 or SD-A8 did not change over background levels. These
results suggested that M3-restricted naive CD8+ T cells are not
activated in mice infected with fmt mutant L. monocytogenes.
JEM VOL. 203, February 20, 2006

Figure 6. M3-restricted CD8+ T cells are not activated during
infection with fmt mutant Listeria. Mice were immunized with PBS
(naive group) or a sublethal dose of either wild-type (10403s) or fmt mutant (SD-A1, SD-A8) L. monocytogenes. 7 d later, the mice were killed and
the number of antigen-specific CD8+ T cells present in the spleen was
determined by IFNγ ICCS. (A) BALB/c splenocytes were exposed to either
1 μM LLO91-99 peptide, which binds to Kd (black bars) or 1 μM fMIGWII
peptide, which binds to M3 (white bars). (B) MHC-Ia–deficient splenocytes
were incubated with either no peptide (gray bars), 1 μM formylated
fMIGWII peptide (black bars), or 1 μM unformylated MIGWII peptide
(white bars). Data shown represent the average number of CD8β+ cells
that were IFNγ+ within each group of mice ± SE from one of three
separate experiments.

To determine whether CD8+ T cells restricted by other
MHC-Ib molecules were being activated in the absence of an
M3-restricted T cell response, we infected MHC-Ia–deficient
mice with a sublethal dose of L. monocytogenes SD-A1. 7 d
later, splenocytes from these mice were incubated with either
uninfected bone marrow–derived macrophages (BMMΦ) or
cells that had been infected with fmt mutant Listeria strain
SD-A1. As shown in Fig. 7 A and Fig. S2 (available at http://
www.jem.org/cgi/content/full/jem.20052256/DC1), a significant number of CD8+ T cells capable of recognizing antigens derived from L. monocytogenes SD-A1 were found in
the spleens of MHC-Ia–deficient mice. Recognition of these
antigens was not blocked by the addition of either anti-M3 or
anti–Qa-1b antibody. Control groups of mice infected with
wild-type Listeria also displayed significant T cell recognition
of infected BMMΦ. However, as expected, pretreatment
with anti-M3 antibody blocked recognition and subsequent
IFNγ expression for a large fraction of the CD8+ T cells
found in these mice (Fig. 7 B). These results suggest that
other antigens besides formylated peptides were presented
387

Figure 7. CD8+ T cells from fmt mutant Listeria-immune mice
recognize antigens presented by an MHC-Ib molecule other than
M3 or Qa-1b. Groups of MHC-Ia–deficient mice were infected with
2,000 CFU of either (A) fmt mutant (Lm SD-A1) or (B) wild-type (Lm
10403s) L. monocytogenes. 7 d after infection, splenocytes from these
mice were harvested and exposed to MHC-Ia–deficient BMMΦ (either
uninfected or cells that had been infected for 3 h with the same strain of
Listeria used to infect the mice). As indicated, some samples of Listeriainfected BMMΦ were pretreated with either anti-M3 or anti–Qa-1b
monoclonal antibody before the addition of immune splenocytes. Data
shown represent the average number of TCRβ+ CD8+ cells that stained
IFNγ+ within each group of mice ± SE from one out of two experiments.

to CD8+ T cells by novel MHC-Ib molecules during both
wild-type and fmt mutant Listeria infection of mice.
Class Ia MHC-deficient mice immunized with fmt mutant
Listeria develop protective immunity against infection with
wild-type Listeria
MHC-Ia–deficient mice are able to clear secondary lethal
challenge with L. monocytogenes as rapidly as wild-type mice
(15, 16) and it has been suggested that M3-restricted CD8+
T cells are largely responsible for this protective immunity
(17). We used the fmt mutant strains of Listeria to determine
whether activation of M3-restricted T cells was required for
protection against secondary Listeria infection in MHC-Ia–
deficient mice. Groups of MHC-Ia–deficient mice were immunized with a sublethal dose of either wild-type or fmt
mutant L. monocytogenes; a control group (naive mice) received PBS. 3 wk later, all groups of mice were challenged
with 5 LD50 of wild-type L. monocytogenes 10403s. 3 d later,
the total number of Listeria CFU present in the spleen or liver
was determined. Mice immunized with wild-type Listeria
had at least two logs fewer bacteria in the spleen or liver compared with naive mice (Fig. 8). Surprisingly, mice immunized
with either SD-A1 or SD-A8 showed the same degree of
protection against high dose secondary infection as was observed after immunization with wild-type L. monocytogenes.
This result indicates that activation of M3-restricted CD8+
T cells was not essential for protective immunity against
L. monoytogenes in these mice and suggests that other MHCIb–restricted T cells may have a significant role in the clearance of Listeria infection.
DISCUSSION
We isolated ActR fmt mutant strains of L. monocytogenes to use
as a tool to address the role of M3-restricted CD8+ T cells in
388

Figure 8. Immunization with fmt mutant Listeria results in full
protective immunity against secondary challenge with wild-type
Listeria. Groups of MHC-Ia–deficient mice were immunized with PBS
(naive) or 103 CFU of either 10403s (wild type) or SD-A1 (fmt mutant)
L. monocytogenes. 3 wk later, all groups of mice were challenged intravenously with 5 × 104 wild-type Listeria. The total number of CFU per organ
was determined 3 d after infection. Similar results were observed for
groups of mice immunized with strain SD-A8 (not depicted). Data shown
represent average values ± SD for groups of mice from one of two
independent experiments.

MHC-Ib–mediated protective immunity against intracellular
bacterial pathogens. While performing assays to characterize
these fmt mutant strains, we discovered several interesting
phenotypes. For example, although the fmt mutant strains
were able to compete with wild-type L. monocytogenes for
growth in the spleen, significantly fewer fmt mutant Listeria
were isolated from the liver. This difference in virulence can
be at least partially explained by the observation that fmt mutant Listeria have a reduced ability to spread from cell-to-cell.
One mechanism for Listeria to prolong survival in the host is
thought to be the ability of the bacteria to spread to a neighboring cell without encountering the extracellular environment, where the bacteria are susceptible to phagocytosis by
activated macrophages or neutrophils. Hepatocytes, which
are readily infected by L. monocytogenes, are connected by cell
junctions within the tissue, and this cell-to-cell contact presumably facilitates spread of the bacteria within the liver. In
contrast, L. monocytogenes infects primarily circulating immune cells (monocytes, macrophages, and dendritic cells) in
the spleen. Thus, the apparent increased virulence of the fmt
mutant L. monocytogenes in the spleen may simply reflect the
fact that efficient cell-to-cell spread of bacteria is not an important feature for growth in the spleen.
Interestingly, the fmt mutant L. monocytogenes had a slight
growth defect in vitro but not in vivo. It has long been
thought that formylation of initiator Met-tRNAs is essential
for protein synthesis in bacteria and in eukaryotic organelles
such as chloroplasts and mitochondria. This belief is based
largely on studies that showed a marked (>10-fold) decrease
in growth of Escherichia coli containing mutations in fmt (24)
and the identification of formylmethionine at the NH2 terminus of several mitochondrial proteins. However, we show
here that mutations in the L. monocytogenes fmt gene have
MTF MUTANT LISTERIA LACK M3-BINDING PEPTIDES | D’Orazio et al.
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only a modest effect on bacterial growth in BHI broth. Other
groups have shown a similar growth phenotype in P. aeruginosa (18) and S. aureus (19). These observations suggest that
formylation may confer a slight advantage for in vitro growth
of most bacterial species, but that only in E. coli has a strict
requirement for fmt activity been demonstrated. Li et al.
showed that protein synthesis could also be initiated in yeast
mitochondria in the absence of formylated methionine (25).
A comparative analysis of the structural requirements for
binding of IF-2 to fMet-tRNA vs. Met-tRNA in each of
these organisms may elucidate the mechanism whereby protein synthesis can readily initiate in the absence of formylmethionine in prokaryotes or in mitochondria.
It is possible that during infection of mice, secondary mutations occurred that allowed the fmt mutant L. monocytogenes
to replicate faster. However, we found that the fmt mutant
strains were replicating at the same rate as wild-type L. monocytogenes after just 1–2 h of infection of tissue culture cells. It
does not seem likely that selective pressures could have resulted in secondary mutations during this short time period.
These data suggest that the cytoplasm of host cells may be an
environment in which the bacterial enzymes involved in formylation are not necessary. Even if secondary mutations did
occur in vivo that resulted in a low level of formylation in the
fmt mutant bacteria, insufficient antigen was presented to activate the immunodominant M3-restricted Listeria-specific
CD8+ T cell population.
During primary Listeria infection, M3-restricted T cells
expand faster than Kd-restricted T cells, with peak numbers
occurring by 5–6 d after infection (8) and it has been shown
that M3-restricted CD8+ T cells alone can clear sublethal
Listeria infections within 5 d (26). The role of M3-restricted
T cells during secondary infection, however, has been less
clear. Kerksiek et al. showed that M3-restricted memory
CD8+ T cell populations are generated and maintained after
primary infection with L. monocytogenes. However, despite
the fact that these memory CD8+ T cells were activated in
the same manner as Kd-restricted T cells, the M3-restricted
CD8+ cells failed to undergo a dramatic proliferative burst
upon rechallenge with Listeria (27). It has been difficult to
determine the precise role of M3-restricted CD8+ T cells
during secondary Listeria infections because of the apparent
paradox that M3-restricted T cells are a dominant fraction of
the MHC-Ib–restricted T cell population (17), yet the recall
expansion of these cells is small and perhaps not significant
enough to clear large bacterial burdens. Hamilton et al. recently suggested that it is the MHC-Ia–restricted T cell response that limits the expansion of M3-restricted memory
CD8+ T cells during secondary challenge (26).
In this report, we show that immunization with an fmt
mutant Listeria strain that lacks formylated peptides still results
in the generation of protective immunity against secondary
Listeria infection. These data argue that activation of M3restricted CD8+ T cells is not essential for protective immunity against Listeria and suggests that presentation of antigen
in the context of other MHC-Ib molecules is sufficient to
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elicit a protective memory CD8+ T cell response. Bouwer
et al. previously showed that Qa-1b–restricted Listeria-specific
cytotoxic T lymphocytes increase in number during L. monocytogenes infection (28). However, like M3-restricted CD8+
T cells, Qa-1b–restricted T cells do not expand significantly
during secondary infection (29). We have previously shown
that in MHC-Ia–deficient mice, the residual population of
MHC-Ib–restricted CD8+ T cells does expand significantly
after both primary and secondary Listeria infection, and that
protective immunity is mediated by CD8+ T cells in these
mice (15). Because neither M3-restricted nor Qa-1b–restricted
CD8+ T cells expand significantly during secondary Listeria
infection, the activated population of CD8+ T cells must recognize L. monocytogenes antigens presented by novel MHC-Ib
molecules. These MHC-Ib–restricted CD8+ T cells appear
to be necessary for clearance of Listeria in the absence of
MHC-Ia–restricted and M3-restricted T cell responses because adoptive transfer of L. monocytogenes SD-A1 immune
splenocytes depleted of CD8+ T cells failed to protect naive
mice from challenge with L. monocytogenes (Fig. S3, available
at http://www.jem.org/cgi/content/full/jem.20052256/DC1).
Further studies will be required to determine whether these
additional MHC-Ib–restricted CD8+ T cell specificities are
involved in protective immunity in wild-type mice.
In the past decade, the majority of studies examining
MHC-Ib–restricted T cells have focused on the recognition
of formylated peptides presented by M3 molecules. The results presented here make a strong argument that a search for
new MHC-Ib molecules capable of presenting antigen to
CD8+ T cells would result in the identification of new antigenic specificities able to protect against secondary Listeria
infection. Further characterization of the unique types of antigens that can be recognized by protective CD8+ T cells will
greatly facilitate the rational design of effective therapeutic
strategies to protect against other intracellular bacteria, including prevalent pathogens such as Mycobacterium tuberculosis
and Chlamydia trachomatis.
MATERIALS AND METHODS
Bacteria. L. monocytogenes fmt mutant strains SD-A1, SD-A4, and SD-A8
were derived from wild-type L. monocytogenes 10403s. L. monocytogenes
10403s has a LD50 of 104 CFU in BALB/c mice. Bacteria were grown in
BHI broth (Difco) supplemented with 100 μg/ml actinonin (Sigma-Aldrich)
as indicated. DNA fragments encoding fmt were amplified from each Listeria
strain using Platinum PCR Supermix (Invitrogen) with the following primers: 3′-GACATGAGCGGACAGGGGAAGT-5′ and 3′-CACCCCGTTGACGAATTTAGTTAC-5′. The DNA sequence of each PCR product was
directly determined using internal primers. Bacterial culture supernatants
were prepared by inoculating BHI broth and incubating with aeration at
37°C for 24 h. Bacteria were centrifuged at 13,000 revolutions/min for
20 min and the supernatant was collected. Aliquots were stored at −20°C
and thawed before use.
Cell culture. EL-4 thymoma cells (H-2b), J774 macrophage-like cells, L2
fibroblasts, and Hepa1-6 hepatoma (epithelial) cells were obtained from the
American Type Culture Collection and were maintained at 37°C in 7%
CO2. EL-4 and J774 cells were grown in RP-10 media consisting of RPMI
1640 (GIBCO BRL) supplemented with l-glutamine, Hepes, 50 μM
2-ME, and 10% FCS; L2 and Hepa1-6 cells were grown in DMEM (GIBCO
389

BRL) plus 10% FCS. T cell lines were maintained by weekly restimulation
on antigen-coated syngeneic splenocytes as described previously (15).
Mice. BALB/c/By/J mice obtained from Jackson ImmunoResearch Laboratories and eleventh backcross generation C.B10-H-2b/LilMcd/J Kb−/−Db−/−
mice (15) were housed in specific pathogen-free animal facilities at Harvard
Medical School (HMS) and the University of Kentucky (UK). The experimental procedures used in this study were approved by IACUC committees
at both HMS and UK. For primary infections, mice were given 103 CFU
of L. monocytogenes i.v. in the tail vein. For secondary challenges, mice were
allowed to recover for 3 wk and infected i.v. with 6 × 104 CFU L. monocytogenes. 3 d after infection, spleen and livers were harvested aseptically, diluted in 0.2% NP-40, and plated on BHI agar to determine the total number
of CFU per organ.
Intracellular growth assay. Cells were seeded on 12-mm round coverslips
and incubated overnight in RP-10 without antibiotics to reach confluence.
Bacteria were grown to early log phase in BHI broth, washed once with
PBS, and used to infect cell monolayers. Cells were infected (on coverslips
in triplicate) at a multiplicity of infection of 0.1 (for J774 cells) or 5.0 (for L2
and Hepa1-6 cells), incubated for 30 min, washed three times with warm
PBS, and RP-10 containing 25 μg/ml gentamicin sulfate was added. At indicated time points, the number of bacteria associated with each coverslip
was determined by placing the coverslip in sterile dH2O, vortexing vigorously for 30 s, and plating dilutions on BHI agar.
T cell cytotoxicity. Target cells were coincubated with either 50 μl of
L. monocytogenes supernatant or synthetic peptide (Bio-Synthesis) and
100 μCi sodium 51chromate for 1 h at 37°C in 7% CO2. The cells were
washed three times with RPMI 1640, suspended in RP-10 at 105 cells/ml
and 100 μl of cells per well was added to 96-well plates. Serial dilutions of
T cells were added in a final volume of 200 μl/well and the plates were incubated for 4 h at 37°C in 7% CO2. Spontaneous release was determined in
wells containing target cells with no T cells; maximum release was determined by the addition of 1% Triton X-100. The cytotoxic activity of the
T cells was evaluated by measuring 51Cr release in the supernatant on a Wallac 1470 Wizard γ counter. Percent specific lysis was calculated using the
following formula: % specific lysis = 100 × [(release by T cells − spontaneous
release) ÷ (maximum release − spontaneous release)].
Competitive index assay. Growth of fmt mutant Listeria strains was compared with growth of wild-type Listeria using a competitive index assay as
described previously (23). In brief, BALB/c mice were infected (i.v.) with a
1:1 mixture of wild-type strain DP-L3903 (ErmR) and one of the fmt mutant
strains. Mice were given a total of 103 CFU and were killed 72 h later.
Spleens and livers were harvested aseptically, homogenized, diluted in 0.2%
NP-40, and plated on BHI agar. At least 100 colonies per organ were replica
plated or patched onto BHI agar containing 2 μg/ml erythromycin. Competitive indices were calculated by dividing the total number of test strain
CFU (SD-A1 or SD-A8; erythromycin-sensitive) by the total number of
reference strain CFU (DP-L3903; erythromycin-resistant).
Plaque assay. Cells were grown to confluence in six-well dishes, infected
with L. monocytogenes for 1 h at various multiplicities of infection, and washed
three times with warm PBS. Overlays consisting of MEM (GIBCO BRL)
containing 2.5% FBS, 1% agarose, and 10 μg/ml gentamicin sulfate were
added and the cells were incubated for an additional 3 d. Plaques were visualized by the addition of neutral red overlays (1% agarose, 0.2% neutral red
in MEM-2.5). Plaque size was measured by analyzing digital images of the
overlays.
ICCS. IFNγ ICCS was performed using the Cytofix/Cytoperm Plus (with
GolgiPlug) kit (BD Biosciences). In brief, splenocytes were harvested from
Listeria-infected mice and 5 × 106 cells/well were added to 24-well dishes.
Synthetic peptides (Bio-Synthesis) corresponding to antigenic epitopes
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were added to some wells at a final concentration of 1 μM. In experiments
where J774 cells were used as targets, 4 × 105 J774 cells per well were infected with L. monocytogenes SD-A1 at a multiplicity of infection of 1.0 for
2 h before the addition of splenocytes. Listeria culture supernatant (50 μl)
was added directly to some wells. After 5–6 h of incubation in the presence of GolgiPlug at 37°C in 7% CO2, cells were stained with anti-CD8α
(53–6.7), anti-CD8β (53–5.8), and anti-TCRb (H57-597) antibodies. The
cells were fixed, permeabilized, and stained with anti-IFNγ (XMG1.2) antibody according to the manufacturer’s instructions. Cells were suspended
in FACS buffer (0.5% BSA, 0.1% NaN3 in HBSS) before flow cytometric
analysis. Fluorescence intensities were measured using a FACSCalibur flow
cytometer (Becton Dickinson) and analysis was performed using CELLQuest software. Dead cells and monocytes were excluded using forward
and side scatter gating. Typically, 100,000 gated events were collected for
each analysis.
Antibody-blocking experiments. CD8+ cells were enriched from whole
splenocytes by negative selection using antibody-conjugated IMag magnetic
beads (BD Biosciences). Typically, the enrichment protocol removed 90–
95% of the splenocytes from MHC-Ia–deficient mice. Listeria-infected or
uninfected MHC-Ia–deficient BMMΦ were pretreated with anti-M3 (clone
130) or anti–Qa-1b (6A8.6F10.1A6) monoclonal antibodies (final concentration 500 μg/ml) for 30 min at room temperature. The antibodies were
maintained at a concentration of 20 μg/ml for 5–6 h during the incubation
of CD8-enriched splenocytes with infected or uninfected macrophages. The
number of IFNγ-secreting CD8+ T cells was determined by ICCS as described in the previous paragraph.
Online supplemental material. Fig. S1 displays primary dot plots from
individual mice representative of the data shown in Fig. 6 A. Fig. S2 includes
primary FACS plots for individual mice representative of the data shown in
Fig. 7. Fig. S3 shows that adoptive transfer of fmt mutant Listeria-immune
spleen depleted of CD8+ T cells does not protect mice as well as whole immune spleen. Online supplemental material is available at http://www.jem.
org/cgi/content/full/jem.20052256/DC1.
We would like to thank J. Mekalanos for helpful discussions about actinonin
resistance, Z. Balsara and D. Higgins for critical review of the manuscript, and
J.N. Lafave and D. McElroy for technical assistance.
This work was supported by National Institutes of Health (NIH) grant nos.
AI055962 and AI41526 (to M.N. Starnbach) and by a pilot grant from the Harvard
Digestive Diseases Center, NIH grant no. DK34854 (to S.E.F. D’Orazio).
The authors have no conflicting financial interests.
Submitted: 9 November 2005
Accepted: 5 January 2006

REFERENCES
1. Busch, D.H., K. Kerksiek, and E.G. Pamer. 1999. Processing of Listeria
monocytogenes antigens and the in vivo T-cell response to bacterial infection. Immunol. Rev. 172:163–169.
2. Geginat, G., S. Schenk, M. Skoberne, W. Goebel, and H. Hof. 2001. A
novel approach of direct ex vivo epitope mapping identifies dominant
and subdominant CD4 and CD8 T cell epitopes from Listeria monocytogenes. J. Immunol. 166:1877–1884.
3. Soloski, M.J., M.E. Szperka, A. Davies, and S.L. Wooden. 2000. Host
immune response to intracellular bacteria: a role for MHC-linked class-Ib
antigen-presenting molecules. Proc. Soc. Exp. Biol. Med. 224:231–239.
4. Forman, J., and K.F. Lindahl. 2002. Listing, Location, Binding Motifs,
and Expression of Nonclassical Class I and Related Genes and Molecules.
In Current Protocols in Immunology. John Wiley & Sons, Hoboken,
NJ. A.1M1–A.1M13.
5. Shawar, S.M., J.M. Vyas, J.R. Rodgers, and R.R. Rich. 1994. Antigen
presentation by major histocompatibility complex class Ib molecules.
Annu. Rev. Immunol. 12:839–880.
6. Gumperz, J.E., and M.B. Brenner. 2001. CD1-specific T cells in microbial immunity. Curr. Opin. Immunol. 13:471–478.
MTF MUTANT LISTERIA LACK M3-BINDING PEPTIDES | D’Orazio et al.

ART I CL E

7. Ulrichs, T., D.B. Moody, E. Grant, S.H.E. Kaufmann, and S.A. Porcelli.
2003. T-cell responses to CD1-presented lipid antigens in humans with
Mycobacterium tuberculosis infection. Infect. Immun. 71:3076–3087.
8. Kerksiek, K.M., D.H. Busch, I.M. Pilip, S.E. Allen, and E.G. Pamer.
1999. H2-M3–restricted T cells in bacterial infection: rapid primary but
diminished memory responses. J. Exp. Med. 190:195–204.
9. Loveland, B., C.-R. Wang, H. Yonekawa, E. Hermel, and K.F.
Lindahl. 1990. Maternally transmitted histocompatibility antigen of
mice: a hydrophobic peptide of a mitochondrially encoded protein.
Cell. 60:971–980.
10. Shawar, S., R. Cook, J. Rodgers, and R. Rich. 1990. Specialized
functions of MHC class I molecules. I. An N-formyl peptide receptor
is required for construction of the class I antigen Mta. J. Exp. Med.
171:897–912.
11. Wang, C., A. Castano, P. Peterson, C. Slaughter, and K. Lindahl. 1995.
Nonclassical binding of formylated peptide in crystal structure of the
MHC class Ib molecule H2-M 3. Cell. 82:655–664.
12. Lenz, L.L., B. Dere, and M.J. Bevan. 1996. Identification of an H2-M3restricted Listeria epitope: implications for antigen presentation by M 3.
Immunity. 5:63–72.
13. Pamer, E.G., C.-R. Wang, L. Flaherty, K.F. Lindahl, and M.J. Bevan.
1992. H2-M3 presents a Listeria monocytogenes peptide to cytotoxic
T lymphocytes. Cell. 70:215–223.
14. Princiotta, M.F., L.L. Lenz, M.J. Bevan, and U.D. Staerz. 1998. H2-M3
restricted presentation of a Listeria-derived leader peptide. J. Exp. Med.
187:1711–1719.
15. D’Orazio, S.E.F., D.H. Gould, H.L. Ploegh, and M.N. Starnbach.
2003. Class Ia MHC-deficient BALB/c mice generate CD8+ T cell
mediated protective immunity against Listeria monocytogenes infection.
J. Immunol. 171:291–298.
16. Seaman, M.S., B. Perarnau, K.F. Lindahl, F.A. Lemmonier, and J.
Forman. 1999. Response to Listeria monocytogenes in mice lacking MHC
class Ia molecules. J. Immunol. 162:5429–5436.
17. Seaman, M.S., C.-R. Wang, and J. Forman. 2000. MHC class Ib-restricted CTL provide protection against primary and secondary Listeria
monocytogenes infection. J. Immunol. 165:5192–5201.
18. Newton, D.T., C. Creuzenet, and D. Mangroo. 1999. Formylation is
not essential for initiation of protein synthesis in all eubacteria. J. Biol.
Chem. 274:22143–22146.

JEM VOL. 203, February 20, 2006

19. Margolis, P.S., C.J. Hackbarth, D.C. Young, W. Wang, D. Chen, Z.
Yuan, R. White, and J. Trias. 2000. Peptide deformylase in Staphylococcus
aureus: resistance to inhibition is mediated by mutations in the formyltransferase gene. Antimicrob. Agents Chemother. 44:1825–1831.
20. Chen, D.Z., D.V. Patel, C.J. Hackbarth, W. Wang, G. Dreyer, D.C.
Young, P.S. Margolis, C. Wu, Z.-J. Ni, J. Trias, et al. 2000. Actinonin,
a naturally occurring antibacterial agent, is a potent deformylase inhibitor. Biochemistry. 39:1256–1262.
21. Meinnel, T., Y. Mechulam, and S. Blanquet. 1993. Methionine as
a translation start signal: a review of the enzymes of the pathway in
Escherichia coli. Biochimie. 75:1061–1075.
22. Lenz, L.L. 1998. Presentation of Formylated Bacterial Peptides to
Cytotoxic T Cells by an MHC Class Ib Molecule. In Department of
Immunology. University of Washington, Seattle, WA. 24–34.
23. Auerbuch, V., L.L. Lenz, and D.A. Portnoy. 2001. Development of
a competitive index assay to evaluate the virulence of Listeria monocytogenes actA mutants during primary and secondary infection of mice.
Infect. Immun. 69:5953–5957.
24. Guillon, J.M., Y. Mechulam, J.M. Schmitter, S. Blanquet, and G.
Fayat. 1992. Disruption of the gene for Met-tRNA(fMet) formyltransferase severely impairs the growth of Escherichia coli. J. Bacteriol.
174:4294–4301.
25. Li, Y., W.B. Holmes, D.R. Appling, and U.L. RajBhandary. 2000.
Initiation of protein synthesis in Saccharomyces cerevisiae mitochondria
without formylation of the initiator tRNA. J. Bacteriol. 182:2886–2892.
26. Hamilton, S.E., B.B. Porter, K.A.N. Messingham, V.P. Badinovac, and
J.T. Harty. 2004. MHC class Ia-restricted memory T cells inhibit expansion of a nonprotective MHC class Ib (H2-M3)-restricted memory
response. Nat. Immunol. 5:159–168.
27. Kerksiek, K.M., A. Ploss, I. Leiner, D.H. Busch, and E.G. Pamer. 2003.
H2-M3-restricted memory T cells: persistence and activation without
expansion. J. Immunol. 170:1862–1869.
28. Bouwer, H.G.A., M.S. Seaman, J. Forman, and D.J. Hinrichs. 1997.
MHC Class Ib-restricted cells contribute to antilisterial immunity.
J. Immunol. 159:2795–2801.
29. Bouwer, H.G.A., R.A. Barry, and D.J. Hinrichs. 2001. Lack of expansion of major histocompatibility complex class Ib-restricted effector
cells following recovery from secondary infection with the intracellular
pathogen Listeria monocytogenes. Infect. Immun. 69:2286–2292.

391

